Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 204

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Machine learning in preclinical drug discovery

Catacutan, Denise B., Alexander, Jeremie, Arnold, Autumn, Stokes, Jonathan M. · 2024 · Nature Chemical Biology

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41589-024-01679-1

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Research works printed but not linked: 71

  1. Schenone, M., Dančík, V., Wagner, B. K. & Clemons, P. A. Target identification and mechanism of action in chemical biology and drug discovery. Nat. Chem. Biol. 9, 232–240 (2013). · DOI · Paper page
  2. Ashenden, S. K. in The Era of Artificial Intelligence, Machine Learning, and Data Science in the Pharmaceutical Industry Ch. 6 (Elsevier, 2021). · DOI
  3. Janai, J., Güney, F., Behl, A. & Geiger, A. Computer vision for autonomous vehicles: problems, datasets and state of the art. Found. Trends Comp. Graph. Vis. 12, 1–308 (2020).
  4. Peterson, A. A. & Liu, D. R. Small-molecule discovery through DNA-encoded libraries. Nat. Rev. Drug Discov. 22, 699–722 (2023). · DOI · Paper page
  5. Lim, K. S. et al. Machine learning on DNA-encoded library count data using an uncertainty-aware probabilistic loss function. J. Chem. Inf. Model. 62, 2316–2331 (2022). · DOI
  6. Hou, R., Xie, C., Gui, Y., Li, G. & Li, X. Machine-learning-based data analysis method for cell-based selection of DNA-encoded libraries. ACS Omega 8, 19057–19071 (2023). · DOI
  7. Van de Sande, B. et al. Applications of single-cell RNA sequencing in drug discovery and development. Nat. Rev. Drug Discov. 22, 496–520 (2023). · DOI · Paper page
  8. Chen, J. et al. Deep transfer learning of cancer drug responses by integrating bulk and single-cell RNA-seq data. Nat. Commun. 13, 6494 (2022). · DOI · Paper page
  9. Godinez, W. J., Hossain, I., Lazic, S. E., Davies, J. W. & Zhang, X. A multi-scale convolutional neural network for phenotyping high-content cellular images. Bioinformatics 33, 2010–2019 (2017). · DOI · Paper page
  10. Jin, W. et al. Deep learning identifies synergistic drug combinations for treating COVID-19. Proc. Natl Acad. Sci. USA 118, e2105070118 (2021). · DOI · Paper page
  11. Rogers, D. & Hahn, M. Extended-connectivity fingerprints. J. Chem. Inf. Model. 50, 742–754 (2010). · DOI · Paper page
  12. Fernández-De Gortari, E., García-Jacas, C. R., Martinez-Mayorga, K. & Medina-Franco, J. L. Database fingerprint (DFP): an approach to represent molecular databases. J. Cheminform. 9, 9 (2017).
  13. Liu, G. et al. Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii. Nat. Chem. Biol. https://doi.org/10.1038/s41589-023-01349-8 (2023). · DOI · Paper page
  14. Corsello, S. M. et al. The Drug Repurposing Hub: a next-generation drug library and information resource. Nat. Med. 23, 405–408 (2017). · DOI · Paper page
  15. Wong, F. et al. Discovery of a structural class of antibiotics with explainable deep learning. Nature 626, 177–185 (2024). · DOI · Paper page
  16. Tropsha, A., Isayev, O., Varnek, A., Schneider, G. & Cherkasov, A. Integrating QSAR modelling and deep learning in drug discovery: the emergence of deep QSAR. Nat. Rev. Drug Discov. 23, 141–155 (2024). · DOI · Paper page
  17. Rossetti, G. G. et al. Non-covalent SARS-CoV-2 Mpro inhibitors developed from in silico screen hits. Sci. Rep. 12, 2505 (2022). · DOI
  18. Anstine, D. M. & Isayev, O. Generative models as an emerging paradigm in the chemical sciences. J. Am. Chem. Soc. 145, 8736–8750 (2023). · DOI · Paper page
  19. Jin, W., Barzilay, R. & Jaakkola, T. Junction tree variational autoencoder for molecular graph generation. Preprint at arxiv.org/abs/1802.04364 (2018). · arXiv
  20. Godinez, W. J. et al. Design of potent antimalarials with generative chemistry. Nat. Mach. Intell. 4, 180–186 (2022). · DOI
  21. Cesaro, A., Bagheri, M., Torres, M., Wan, F. & de la Fuente-Nunez, C. Deep learning tools to accelerate antibiotic discovery. Expert Opin. Drug Discov. 18, 1245–1257 (2023). · DOI
  22. Rezende, D. J. & Mohamed, S. Variational inference with normalizing flows. In Proc. 32nd International Conference on Machine Learning 2, 1530–1538 (PMLR, 2015).
  23. Shekhovtsov, A., Schlesinger, D. & Flach, B. VAE approximation error: ELBO and exponential families. Preprint at arxiv.org/abs/2102.09310 (2021). · arXiv
  24. Shi, C. et al. GraphAF: a flow-based autoregressive model for molecular graph generation. Preprint at arxiv.org/abs/2001.09382 (2020). · arXiv
  25. Hoogeboom, E., Satorras, V. G., Vignac, C. & Welling, M. Equivariant diffusion for molecule generation in 3D. In Proc. 39th International Conference on Machine Learning 8867–8887 (2022).
  26. Weininger, D. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J. Chem. Inf. Model. 28, 31–36 (1988).
  27. Grisoni, F. Chemical language models for de novo drug design: challenges and opportunities. Curr. Opin. Struct. Biol. 79, 102527 (2023). · DOI
  28. Flam-Shepherd, D., Zhu, K. & Aspuru-Guzik, A. Language models can learn complex molecular distributions. Nat. Commun. 13, 3293 (2022). · DOI · Paper page
  29. Skinnider, M. A., Greg Stacey, R., Wishart, D. S. & Foster, L. J. Chemical language models enable navigation in sparsely populated chemical space. Nat. Mach. Intell. 3, 759–770 (2021). · DOI · Paper page
  30. Moret, M., Friedrich, L., Grisoni, F., Merk, D. & Schneider, G. Generative molecular design in low data regimes. Commun. Chem. 5, 129 (2022). · DOI
  31. Ballarotto, M. et al. De novo design of Nurr1 agonists via fragment-augmented generative deep learning in low-data regime. J. Med. Chem. 66, 8170–8177 (2023). · DOI
  32. Moret, M. et al. Leveraging molecular structure and bioactivity with chemical language models for de novo drug design. Nat. Commun. 14, 114 (2023). · DOI · Paper page
  33. Grisoni, F. et al. Combining generative artificial intelligence and on-chip synthesis for de novo drug design. Sci. Adv. 7, 3338–3349 (2021). · DOI · Paper page
  34. Vaswani, A. et al. Attention is all you need. Preprint at arxiv.org/abs/1706.03762 (2023). · arXiv
  35. Bagal, V., Aggarwal, R., Vinod, P. K. & Priyakumar, U. D. MolGPT: molecular generation using a transformer-decoder model. J. Chem. Inf. Model. 62, 2064–2076 (2021). · DOI · Paper page
  36. Born, J. & Manica, M. Regression Transformer enables concurrent sequence regression and generation for molecular language modelling. Nat. Mach. Intell. 5, 432–444 (2023). · DOI
  37. Grechishnikova, D. Transformer neural network for protein-specific de novo drug generation as a machine translation problem. Sci. Rep. 11, 321 (2021). · DOI · Paper page
  38. Stsiapanava, A. et al. Structure of the decoy module of human glycoprotein 2 and uromodulin and its interaction with bacterial adhesin FimH. Nat. Struct. Mol. Biol. 29, 190–193 (2022). · DOI
  39. Liu, H. et al. Cryo-EM structures of human hepatitis B and woodchuck hepatitis virus small spherical subviral particles. Sci. Adv. 8, eabo4184 (2022). · DOI
  40. Yang, Q. et al. Structural comparison and drug screening of spike proteins of ten SARS-CoV-2 variants. Research 2022, 9781758 (2022).
  41. Yang, Q., Xia, D., Syed, A. A. S., Wang, Z. & Shi, Y. Highly accurate protein structure prediction and drug screen of monkeypox virus proteome. J. Infect. 86, 66–117 (2023). · DOI
  42. Berman, H. M. The Protein Data Bank. Nucleic Acids Res. 28, 235–242 (2000). · DOI · Paper page
  43. Michaud, J. M., Madani, A. & Fraser, J. S. A language model beats AlphaFold2 on orphans. Nat. Biotechnol. 40, 1576–1577 (2022). · DOI
  44. Fang, X. et al. A method for multiple-sequence-alignment-free protein structure prediction using a protein language model. Nat. Mach. Intell. 5, 1087–1096 (2023). · DOI · Paper page
  45. Corso, G., Stärk, H., Barzilay, R. & Jaakkola, T. DiffDock: diffusion steps, twists, and turns for molecular docking. Preprint at arxiv.org/abs/2210.01776 (2022). · arXiv
  46. Goodnow, R. A. Hit and lead identification: integrated technology-based approaches. Drug Discov. Today Technol. 3, 367–375 (2006). · DOI
  47. Yang, L. et al. Transformer-based deep learning method for optimizing ADMET properties of lead compounds. Phys. Chem. Chem. Phys. 25, 2377–2385 (2023).
  48. Chen, Y., Yu, X., Li, W., Tang, Y. & Liu, G. In silico prediction of hERG blockers using machine learning and deep learning approaches. J. Appl. Toxicol. 43, 1462–1475 (2023). · DOI
  49. Sharma, B. et al. Accurate clinical toxicity prediction using multi-task deep neural nets and contrastive molecular explanations. Sci. Rep. 13, 4908 (2023). · DOI
  50. Lipinski, C. A. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov. Today Technol. 1, 337–341 (2004). · DOI · Paper page
  51. Coutinho, A. L. et al. A robust, viable, and resource sparing HPLC-based log P method applied to common drugs. Int. J. Pharm. 644, 123325 (2023). · doi:10.1016/j.ijpharm.2023.123325
  52. Faller, B. & Ertl, P. Computational approaches to determine drug solubility. Adv. Drug Deliv. Rev. 59, 533–545 (2007). · DOI · Paper page
  53. Aliagas, I., Gobbi, A., Lee, M. L. & Sellers, B. D. Comparison of log P and log D correction models trained with public and proprietary data sets. J. Comput. Aided Mol. Des. 36, 253–262 (2022). · doi:10.1007/s10822-022-00450-9
  54. Win, Z. M., Cheong, A. M. Y. & Hopkins, W. S. Using machine learning to predict partition coefficient (log P) and distribution coefficient (log D) with molecular descriptors and liquid chromatography retention time. J. Chem. Inf. Model. 63, 1906–1913 (2023). · DOI
  55. Domingo-Almenara, X. et al. The METLIN small molecule dataset for machine learning-based retention time prediction. Nat. Commun. 10, 5811 (2019). · DOI · Paper page
  56. Datta, R., Das, D. & Das, S. Efficient lipophilicity prediction of molecules employing deep-learning models. Chemometr. Intell. Lab. Syst. 213, 104309 (2021). · DOI
  57. Prasad, S. & Brooks, B. R. A deep learning approach for the blind log P prediction in SAMPL6 challenge. J. Comput. Aided Mol. Des. 34, 535–542 (2020). · DOI
  58. Heijman, J., Voigt, N., Carlsson, L. G. & Dobrev, D. Cardiac safety assays. Curr. Opin. Pharmacol. 15, 16–21 (2014). · DOI
  59. Huang, R. et al. Tox21Challenge to build predictive models of nuclear receptor and stress response pathways as mediated by exposure to environmental chemicals and drugs. Front. Environ. Sci. https://doi.org/10.3389/fenvs.2015.00085 (2016). · DOI · Paper page
  60. Ramakrishnan, R., Dral, P. O., Rupp, M. & von Lilienfeld, O. A. Quantum chemistry structures and properties of 134 kilo molecules. Sci. Data 1, 140022 (2014).
  61. Frye, L., Bhat, S., Akinsanya, K. & Abel, R. From computer-aided drug discovery to computer-driven drug discovery. Drug Discov. Today Technol. 39, 111–117 (2021). · DOI
  62. Zeng, W., Guo, L., Xu, S., Chen, J. & Zhou, J. High-throughput screening technology in industrial biotechnology. Trends Biotechnol. 38, 888–906 (2020). · DOI · Paper page
  63. Sarkar, N. & Stokes, J. M. Practical applications of machine learning for anti-infective drug discovery. Med. Chem. Rev. 14, 345–375 (2023). · DOI
  64. Arnold, A., Alexander, J., Liu, G. & Stokes, J. M. Applications of machine learning in microbial natural product drug discovery. Expert Opin. Drug Discov. 18, 1259–1272 (2023). · DOI
  65. Mullowney, M. W. et al. Artificial intelligence for natural product drug discovery. Nat. Rev. Drug Discov. 22, 895–916 (2023). · DOI · Paper page
  66. Grisoni, F. et al. Designing anticancer peptides by constructive machine learning. ChemMedChem 13, 1300–1302 (2018). · DOI · Paper page
  67. Chen, J., Cheong, H. H. & Siu, S. W. I. xDeep-AcPEP: deep learning method for anticancer peptide activity prediction based on convolutional neural network and multitask learning. J. Chem. Inf. Model. 61, 3789–3803 (2021). · DOI
  68. Walker, A. S. & Clardy, J. A machine learning bioinformatics method to predict biological activity from biosynthetic gene clusters. J. Chem. Inf. Model. 61, 2560–2571 (2021). · DOI
  69. Wellawatte, G. P., Gandhi, H. A., Seshadri, A. & White, A. D. A perspective on explanations of molecular prediction models. J. Chem. Theory Comput. 19, 2149–2160 (2023). · DOI
  70. Cichońska, A. et al. Crowdsourced mapping of unexplored target space of kinase inhibitors. Nat. Commun. 12, 3307 (2021). · DOI
  71. Ketkar, N. in Deep Learning with Python 97–111 (Apress, 2017). · DOI · Paper page

Cited by

See all 204

Metadata

Authors
Catacutan, D. B., Alexander, J., Arnold, A., & Stokes, J. M.
Venue
Nature Chemical Biology
Published
2024-07-19
Volume
20
Issue
8
Pages
960-973
ISSN
  • 1552-4450 (ISSN-L)
  • 1552-4469
OpenAlex
W4400831251
Cited by
204
References
45
FWCI
39.99
Type
journal article
Language
en
Open access
closed
Licence
Funders
  • Gouvernement du Canada | Canadian Institutes of Health Research
  • The Weston Family Foundation, The David Braley Centre for Antibiotic Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Machine learning in preclinical drug discovery. https://app.cochat.ai/papers/10.1038/s41589-024-01679-1
The paper
Catacutan, D. B., Alexander, J., Arnold, A., & Stokes, J. M. (2024). Machine learning in preclinical drug discovery. Nature Chemical Biology. https://doi.org/10.1038/s41589-024-01679-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.